Abstract
The surgical technique itself has emerged as a crucial factor for local recurrence since the popularization of total mesorectal excision for the treatment of rectal cancer. This procedure is associated with lower local recurrence rates after “curative” surgery compared to traditional dissection of the rectum. The aim is to remove an intact mesorectal envelope from the promontorium down to the pelvic floor by sharp dissection with tumorfree margins and without causing injury to the pelvic nerves. However, the description of total mesorectal excision has been confusing. Moreover, the implication that total excision of all the perirectal fat contained within the perirectal fascia en bloc in all patients with rectal cancer can minimize local recurrence remains contentious. Therefore a critical appraisal of the procedure is required. Nonrandomized clinical studies have shown that total mesorectal excision reduces the local recurrence rate and increases disease-free survival in patients with adenocarcinoma of the middle and distal third of the rectum. Circumferential resection margins of 2 mm or more are associated with a lower local recurrence rate. Additional benefits in local control can be obtained with neoadjuvant treatment. Thus the modern treatment of rectal cancer combining total mesorectal excision with neoadjuvant chemoradiation results in excellent local tumor control. However, it is achieved at the cost of significant functional sequelae and impaired quality of life. The development of therapeutic alternatives that can achieve similar rates of local and distant tumor control without the mortality, morbidity, and functional consequences of radical surgery is a major challenge for colorectal surgeons.
Résumé
Depuis la popularisation de l’excision mésorectale totale (TME) pour le traitement du cancer rectal, la qualité de la technique chirurgicale tend à émerger comme facteur crucial dans la prévalence de récidive. Ce procédé est associé à un taux de récidive locale plus bas après chirurgie à visée “curative” comparé au taux de récidive après dissection traditionnelle du rectum. Le but de la TME est d’enlever par une dissection précise, instrumentale, l’enveloppe mésorectale intacte entre le niveau du promontoire jusqu’au plancher pelvien, en obtenant des marges de sécurité sans tissu tumoral, et sans provoquer de lésions nerveuses au niveau du pelvis. Cependant, la description de la TME n’est pas claire. De plus, l’implication que l’excision en bloc, de toute la graisse périrectale contenue dans le fascia périrectal, améliore le taux de récidive locale chez tous les patients reste discutée. Ainsi une évaluation critique du procédé est nécessaire. Les études cliniques non randomisées ont montré que la TME réduit le taux de récidive locale et augmente la survie sans maladie chez les patients atteints d’adénocarcinome du rectum moyen et distal. Des marges circonférentielles de 2 mm ou plus sont associées à un taux de récidive locale plus bas. On peut encore augmenter ces bénéfices dans le contrôle local du cancer du rectum par un traitement néoadjuvant Ainsi le traitement moderne du cancer rectal associe la TME à une chimioradiothérapie adjuvante et donne un excellent contrôle local de la tumeur. Cependant, ce contrôle est obtenu grâce à d’importantes séquelles fonctionnelles et des conséquences néfastes pour la qualité de vie. Le développement d’alternatives thérapeutiques capables d’obtenir des résultats similaires en ce qui concerne la récidive locale et à distance mais sans la mortalité, la morbidité et les conséquences fonctionnelles de la chirurgie radicale, reste le principal challenge futur pour les chirurgiens colorectaux.
Resumen
La técnica quirúrgica ha surgido como un factor de importancia crucial en cuanto a recurrencia local desde la popularizatión de la resectión mesorrectal total en el tratamiento del cáncer rectal. El procedimiento se asocia con menores tasas de recurrencia tras de cirugía “curativa” en comparaciôn con la disección tradicional del recto. El propósito de la operatión es resecar la envoltura mesorrectal desde el peritoneo hasta el piso pélvico, mediante disección no roma, con márgenes libres de tumor y evitando lesión de los nervios pélvicos. Sin embargo, la descriptión de la resección mesorrectal total ha sido confusa. Además, la implicación de que la resección total en bloque de la grasa perirrectal contenida por la fascia perirrectal en todos los pacientes con cáncer rectal minimiza la tasa de recurrencia sigue siendo motivo de controversia, por lo cual se hace necesaria una evaluación crítica del procedimiento. Estudios clínicos no aleatorizados han demostrado que la resección mesorrectal total reduce la tasa de recurrencia local y aumenta la supervivencia libre de enfermedad en pacientes con adenocarcinomas de los tercios medio y distal del recto. La resección circunferencial con márgenes de 2 mm o más se asocia con menores tasas de recurrencia. Beneficios adicionales pertinentes al control local se pueden obtener con terapia neoadyuvante. Por consiguiente, el tratamiento moderno del cáncer rectal que combina la resección mesorrectal total con quimio-radiación neoadyuvante resulta en excelente control local del tumor. Sin embargo, esto se logra a costa de secuelas funcionales significativas y desmejoramiento de la calidad de vida. El desarrollo de modalidades terapéuticas alternativas que logren tasas similares de control local y distal del tumor sin la mortalidad, morbilidad y consecuencias funcionales de la cirugía radical, constituye el gran desafío que se plantea a los cirujanos colorrectales.
Article PDF
Avoid common mistakes on your manuscript.
References
Kapiteijn E, van de Velde CJH. The role of total mesorectal excision in the management of rectal cancer. Surg. Clin. North Am. 2002;82:995–1007
Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery: the clue to pelvic recurrence? Br. J. Surg. 1982;69:613–616
Isbister WH. Total mesorectal excision: a fashionable fable or a timely truth. Dig. Surg. 1999;16:367–371
Heald RJ. The Basingstoke view: it is most certainly a timely truth. Dig. Surg. 1999;16:372–374
Silen W. Mesorectal excision for rectal cancer [letter to the editor]. Lancet 1993;341:1279–1280
Nano M, Levi AC, Borghi F, et al. Observations on surgical anatomy for rectal cancer surgery. Hepatogastroenterology 1998;45:717–726
Quirke P, Durdey P, Dixon MF, et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumor spread and surgical excision. Lancet 1986;2:996–999
Aitken RJ. Mesorectal excision for rectal cancer. Br. J. Surg. 1996;83:214–216
Belli L, Beati CA, Frangi M, et al. Outcome of patients with rectal cancer treated by stapled anterior resection. Br. J. Surg. 1988;85:422–444
Cawthorn SJ, Parums DV, Gibbsw NM, et al. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet 1990;335:1055–1059
Colombo PL, Foglieni CL, Morone C. Analysis of recurrence following curative low anterior resection and stapled anastomoses for carcinoma of the middle third and lower rectum. Dis. Colon Rectum 1987;30:457–464
Dixon AR, Maxwell WA, Holmes JT. Carcinoma of the rectum: a 10-year experience. Br. J. Surg. 1990;78:308–311
Eu KW, Seow CF, Ho JM, et al. Local recurrence following rectal resection for cancer. J. R. Coll. Surg. Edinb. 1998;43:393–396
Hainsworth PJ, Egan MJ, Cunliffe WJ. Evaluation of a policy of total mesorectal excision for rectal and rectosigmoid cancers. Br. J. Surg. 1997;84:652–656
Heald RJ, Karanjia ND. Results. World J. Surg. 1992;16:848–857
Jatzko G, Lisborg P, Wette V. Improving survival rates for patients with colorectal cancer. Br. J. Surg. 1992;79:588–591
Kapiteijn E, Putter H, van de Velde CJ. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br. J. Surg. 2002;89:1142–1149
Kirwan WO, O’Riordain MF, Waldron R. Declining indications for abdominoperineal resection. Br. J. Surg. 1989;76:1061–1063
Maas CP, Moriya Y, Steup WH, et al. A prospective study on radical and nerve-preserving surgery for rectal cancer in The Netherlands. Eur. J. Surg. Oncol. 2000;26:751–757
Moran BJ, Blenkinsop J, Finnis D. Local recurrence after anterior resection for rectal cancer using a double stapling technique. Br. J. Surg. 1992;79:836–838
Tagliacozzo S, Accordino M. Pelvic recurrence after surgical treatment of rectal and sigmoid cancer. A prospective clinical trial on 274 patients. Int. J. Colorectal Dis. 1992;7:135–140
Tocchi A, Mazzoni G, Lepre L, et al. Total mesorectal excision and low rectal anastomosis for the treatment of rectal cancer and prevention of pelvic recurrences. Arch. Surg. 2001;136:216–220
Hall NR, Finan PJ, Al-Jaberi T, et al. Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent: predictor of survival but not local recurrence? Dis. Colon Rectum 1998;41: 979–983
Nagtegaal ID, Marijnen CA, Kranenbarg EK, et al. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am. J. Surg. Pathol. 2002;26:350–357
Lopez-Kostner F, Lavery IC, Hool GR, et al. Total mesorectal excision is not necessary for cancers of the upper rectum. Surgery 1998;124:612–618
Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radio-therapy combined with total mesorectal excision for resectable rectal cancer. N. Engl. J. Med. 2001;345:638–646
Carlsen E, Schlichting E, Guldvog I, et al. Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br. J. Surg. 1998;85:526–529
O’Leary DP, Fide CJ, Foy C, et al. Quality of life after low anterior resection with total mesorectal excision and temporary loop ileostomy for rectal carcinoma. Br. J. Surg. 2001;88:1216–1220
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fernández-Represa, J.A., Mayol, J.M. & Garcia-Aguilar, J. Total mesorectal excision for rectal cancer: The truth lies underneath. World J. Surg. 28, 113–116 (2004). https://doi.org/10.1007/s00268-003-7284-1
Issue Date:
DOI: https://doi.org/10.1007/s00268-003-7284-1